To compare short acting effect of Shamak Yog with Sarpagandha churna on stage -1 Essential Hypertension

A Randomized controlled trial to study Short acting effect of Shamak Yog vs Sarpagandha Churna on stage-1 Essential Hypertension - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088323

Enrollment

152

Registered

2025-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Stage-1 Essential Hypertension. Systolic Blood pressure 141 159 mmHg. Diastolic blood pressure 91 99 mmHg. Age criteria 30-50 yrs. Patients willing to take treatment after written informed consent.

Exclusion criteria

Exclusion criteria: Stage 2 and Stage 3 Hypertension. All the patients of secondary hypertension. Patient in Critical condition.

Design outcomes

Primary

Measure	Time frame
To study the short acting effect of Shamak yoga on Stage 1 essential Hypertension.Timepoint: At the end of 120 minutes.	—

Secondary

Measure	Time frame
To find out better drug on Stage 1 essential HypertensionTimepoint: At the end of 120 minutes	—

Countries

India

Contacts

Public ContactDr Madhuri Santosh Phaltankar

Shri Ayurveda Mahavidyalaya Nagpur

mrityunjaysharma22@yahoo.co.in9373103182

Outcome results